ABOUT 17th_ELSF
​> ATTENDEES​
​> INVESTORS​
​> PRESENTERS​
​> EXHIBITORS​
​> SPONSORS​
​> SUPPORTERS​

silver sponsor

Stifel

Stifel is a full-service investment bank with deep industry experience. We serve as strategic advisors to entrepreneurs, family-owned businesses, private equity groups, and leading public and private corporations in North America, Europe, Asia, and Latin America.

Our full-service healthcare investment banking practice offers a best-in-class combination of deep sector knowledge, strong industry relationships, and broad product expertise.

We are not bound by borders. We stand ready to provide the insight and expertise you require. Our integrated approach allows us to deliver the full capabilities of Stifel’s institutional capital markets platform and retail brokerage network, which are among the most highly regarded in the industry.

https://stifelinstitutional.com/capabilities/investment-banking/industry-coverage/healthcare/

bronze sponsors

Biosaxony Management GmbH

BIOSAXONY, the visionary cluster for biotech, medtech and health industry in Central Germany, is forming a unique alliance of national and international life science stakeholders and a strong clinical ecosystem within the heart of Europe. We initiate innovative projects between industry and science and operate the innovation center BIO CITY Leipzig. With MEDICAL FORGE we provide an accelerator for international medtech teams, with 12 months intensive coaching, state of-the-art coworking laboratories and exclusive access to our extensive clinical and industrial network. Application is open until: 30.11.2024 on the website.

https://www.biosaxony.com / https://medicalforge.de

Invest Hong Kong

Invest Hong Kong is the Investment Agency for the Hong Kong Government. We are able to offer you a multitude of grants and tax incentives when doing R&D or Clinical Trials in Hong Kong as well as in-depth market research and unique business opportunities. We became the leading Biotech IPO Destination in Asia and related we would like to discuss with you how to proliferate your company within our hub. We are seeking promising biomedical companies inspired to conduct R&D works in Hong Kong within Infectious Diseases, CNS, Immune Disorders, Cardiovascular, Oncology, Digital Health and Medical AI.

www.investhk.gov.hk/en/home.html

contributing sponsor

Novo Holdings A/S

Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation.

Wholly owned by the Novo Nordisk Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novozymes A/S and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seeds, Venture, Growth, and Principal Investments teams, Novo Holdings invests in life science companies at all stages of development.
              
As of year-end 2022, Novo Holdings had total assets of EUR 108 billion.

www.novoholdings.dk